Melanie A Blair1, Jennifer L Stewart2, April C May3, Martina Reske4, Susan F Tapert3, Martin P Paulus5. 1. Department of Psychology, Graduate Center, City University of New York, New York, New York; Department of Psychology, Queens College, City University of New York, New York, New York. Electronic address: melanie.blair@qc.cuny.edu. 2. Department of Psychology, Graduate Center, City University of New York, New York, New York; Department of Psychology, Queens College, City University of New York, New York, New York. 3. Department of Psychiatry, University of California, San Diego, La Jolla, California. 4. Institute of Neuroscience and Medicine, Computational and Systems Neuroscience, Jülich Research Centre, Jülich, Germany. 5. Laureate Institute of Brain Research, Tulsa, Oklahoma.
Abstract
BACKGROUND: Occasional recreational stimulant (amphetamine and cocaine) use is an important public health problem among young adults because 16% of those who experiment develop stimulant use disorder. This study aimed to determine whether behavioral and/or neural processing measures can forecast the transition from occasional to problematic stimulant use. METHODS: Occasional stimulant users completed a Risky Gains Task during functional magnetic resonance imaging and were followed up 3 years later. Categorical analyses tested whether blood oxygen level-dependent (BOLD) responses differentiated occasional stimulant users who became problem stimulant users (n = 35) from those who desisted from stimulant use (n = 75) at follow-up. Dimensional analyses (regardless of problem stimulant user or desisted stimulant use status; n = 144) tested whether BOLD responses predicted baseline and follow-up stimulant and marijuana use. RESULTS: Categorical results indicated that relative to those who desisted from stimulant use, problem stimulant users 1) made riskier decisions after winning feedback; 2) exhibited lower frontal, insular, and striatal BOLD responses to win/loss feedback after making risky decisions; and 3) displayed lower thalamic but greater temporo-occipital BOLD responses to risky losses than to risky wins. In comparison, dimensional results indicated that lower BOLD signals to risky choices than to safe choices in frontal, striatal, and additional regions predicted greater marijuana use at follow-up. CONCLUSIONS: Taken together, blunted frontostriatal signals during risky choices may quantify vulnerability to future marijuana consumption, whereas blunted frontostriatal signals to risky outcomes mark risk for future stimulant use disorder. These behavioral and neural processing measures may prove to be useful for identifying ultra-high risk individuals prior to onset of problem drug use.
BACKGROUND: Occasional recreational stimulant (amphetamine and cocaine) use is an important public health problem among young adults because 16% of those who experiment develop stimulant use disorder. This study aimed to determine whether behavioral and/or neural processing measures can forecast the transition from occasional to problematic stimulant use. METHODS: Occasional stimulant users completed a Risky Gains Task during functional magnetic resonance imaging and were followed up 3 years later. Categorical analyses tested whether blood oxygen level-dependent (BOLD) responses differentiated occasional stimulant users who became problem stimulant users (n = 35) from those who desisted from stimulant use (n = 75) at follow-up. Dimensional analyses (regardless of problem stimulant user or desisted stimulant use status; n = 144) tested whether BOLD responses predicted baseline and follow-up stimulant and marijuana use. RESULTS: Categorical results indicated that relative to those who desisted from stimulant use, problem stimulant users 1) made riskier decisions after winning feedback; 2) exhibited lower frontal, insular, and striatal BOLD responses to win/loss feedback after making risky decisions; and 3) displayed lower thalamic but greater temporo-occipital BOLD responses to risky losses than to risky wins. In comparison, dimensional results indicated that lower BOLD signals to risky choices than to safe choices in frontal, striatal, and additional regions predicted greater marijuana use at follow-up. CONCLUSIONS: Taken together, blunted frontostriatal signals during risky choices may quantify vulnerability to future marijuana consumption, whereas blunted frontostriatal signals to risky outcomes mark risk for future stimulant use disorder. These behavioral and neural processing measures may prove to be useful for identifying ultra-high risk individuals prior to onset of problem drug use.
Authors: B Behan; C G Connolly; S Datwani; M Doucet; J Ivanovic; R Morioka; A Stone; R Watts; B Smyth; H Garavan Journal: Neuropharmacology Date: 2013-06-18 Impact factor: 5.250
Authors: Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; David Alexoff; Jean Logan; Millard Jayne; Christopher Wong; Dardo Tomasi Journal: Proc Natl Acad Sci U S A Date: 2014-07-14 Impact factor: 11.205
Authors: Matthias Vonmoos; Lea M Hulka; Katrin H Preller; Daniela Jenni; Markus R Baumgartner; Rudolf Stohler; Karen I Bolla; Boris B Quednow Journal: Br J Psychiatry Date: 2013-05-23 Impact factor: 9.319
Authors: Robert Whelan; Richard Watts; Catherine A Orr; Robert R Althoff; Eric Artiges; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Christian Büchel; Fabiana M Carvalho; Patricia J Conrod; Herta Flor; Mira Fauth-Bühler; Vincent Frouin; Juergen Gallinat; Gabriela Gan; Penny Gowland; Andreas Heinz; Bernd Ittermann; Claire Lawrence; Karl Mann; Jean-Luc Martinot; Frauke Nees; Nick Ortiz; Marie-Laure Paillère-Martinot; Tomas Paus; Zdenka Pausova; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Andreas Ströhle; Gunter Schumann; Hugh Garavan Journal: Nature Date: 2014-07-02 Impact factor: 49.962
Authors: Vincent Busch; Henk F Van Stel; Augustinus J P Schrijvers; Johannes R J de Leeuw Journal: BMC Public Health Date: 2013-12-04 Impact factor: 3.295
Authors: Stephanie M Groman; Ansel T Hillmer; Heather Liu; Krista Fowles; Daniel Holden; Evan D Morris; Daeyeol Lee; Jane R Taylor Journal: Biol Psychiatry Date: 2020-02-27 Impact factor: 13.382
Authors: Trevor Steward; Asier Juaneda-Seguí; Gemma Mestre-Bach; Ignacio Martínez-Zalacaín; Nuria Vilarrasa; Susana Jiménez-Murcia; Jose A Fernández-Formoso; Misericordia Veciana de Las Heras; Nuria Custal; Nuria Virgili; Rafael Lopez-Urdiales; Amador García-Ruiz-de-Gordejuela; José M Menchón; Carles Soriano-Mas; Fernando Fernandez-Aranda Journal: J Clin Med Date: 2019-09-27 Impact factor: 4.241